Article

PDF
Access to the PDF text
Advertising



Archives of cardiovascular diseases
Volume 102, n° 2
pages 81-83 (février 2009)
Doi : 10.1016/j.acvd.2008.12.004
Received : 16 December 2008 ;  accepted : 16 December 2008
Should angiotensin-converting enzyme inhibitors be used in all patients with coronary artery disease or restricted to those with a history of myocardial infarction or myocardial revascularization?
Faut-il prescrire des IEC chez tous les coronariens ou restreindre leur utilisation aux patients ayant des antécédents d’infarctus ou de revascularisation myocardique ?
 

Figure 1




Figure 1 : 

Updated meta-analysis of the long-term trials comparing ACE-inhibitors and placebo in coronary artery disease patients without heart failure or left ventricular dysfunction. Abbreviations: CV=cardiovascular; MI=myocardial infarction.

EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline